Molecular docking analysis of Bcl-2 with phyto-compounds

The Bcl-2 protein is liked in several cancers and drug resistance to therapy is also known in this context. There are many Bcl-2 inhibitors under clinical trials. It is of further interest to design new Bcl2 inhibitors from phyto compounds such as artesunate, bruceantin, maytansin, Salvicine, indici...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Bioinformation
Auteurs principaux: Kirubhanand, Chandrasekaran, Selvaraj, Jayaraman, Rekha, Umapathy Vidhya, Vishnupriya, Veeraraghavan, Sivabalan, Venkatachalam, Manikannan, Mathayan, Nalini, Devarajan, Vijayalakshmi, Periyasamy, Rajalakshmi, Manikkam, Ponnulakshmi, Rajagopal
Format: Artigo
Langue:Inglês
Publié: Biomedical Informatics 2020
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7452744/
https://ncbi.nlm.nih.gov/pubmed/32884211
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6026/97320630016468
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires